Specimen Validity Testing Market: Global Industry Analysis and Forecast (2023-2029)

Specimen Validity Testing Market was valued at US$ 2.88 Bn. in 2022 and expected to grow at US$ 5.51 Bn. in 2029. Global Specimen Validity Testing Market size is expected to grow at a CAGR of 9.69 % through the forecast period.
Specimen Validity Testing Market Overview:
Specimen Validity Testing Market was valued at US$ 2.88 Bn. in 2022 and expected to grow at US$ 5.51 Bn. in 2029. Global Specimen Validity Testing Market size is expected to grow at a CAGR of 9.69 % through the forecast period. Specimen validity tests (SVT) are methods used on a urine drug screen specimen to detect for substitution, adulteration, or dilution. With specimen validity testing, we can help ensure the integrity of the test by measuring pH, creatinine and specific gravity (when indicated) and testing for adulterants that may be added to the urine specimen. All three of these important criteria must fall within the range of normal human urine for a urine sample to be considered valid pH is the measurement of acid-base present in the body and specific gravity represents the density of substance compared to the density of water. Specimen validity testing is an important part of every urine drug test. Drug level concentration below the drug metabolite threshold value can generate negative results.

The report explores the Global Specimen Validity Testing Market segments (Product & Services, Type, End User and Region). Data has been provided by market participants, and regions (North America, Asia Pacific, Europe, Middle East & Africa, and South America). The MMR market report provides a thorough analysis of the rapid advances that are currently taking place across all industry sectors. Facts and figures, illustrations, and presentations are used to provide key data analysis for the historical period from 2022 to 2029. The report investigates the Global Specimen Validity Testing Market drivers, limitations, prospects, and barriers. This MMR report includes investor recommendations based on a thorough examination of the Global Specimen Validity Testing Market contemporary competitive scenario.

To know about the Research Methodology :- Request Free Sample Report
Global Specimen Validity Testing Market Dynamics:
The increased number of drug screening labs and diagnostic centres combined with effective testing methods are some crucial factors expected to drive the market and this leads to the prevalence of high drugs across the globe. Moreover, the factors which are spreading the awareness about the global specimen validity testing market are illegal consumption of drugs such as marijuana, heroin, cocaine, hallucinogens, and other non-medical alcoholic fluids and psychotropic medications. The government are also taking initiative to promote drug screening program at workplace for the betterment of the people and it leads to the revenue growth of specimen validity testing market during the forecast period.

SVT is adopted by the law enforcement agencies so as to protect and detect the presence and traces of illicit drugs in criminals & suspects. It helps law enforcement agencies to study the behaviour and cause of why a particular crime is carried out. The global specimen validity testing market is driven by the rise in use of illegal drug. In addition, tight laws required during testing and government financing for reducing the drug addiction are expected to drive the specimen validity testing market globally during the forecast period.

The key factors which are leading the growth of global specimen validity testing market are strong economic growth, an increase in disposable income, an expansion in healthcare infrastructure, and a sudden growth in investment from market players to reduce the misuse of drugs. Drug testing laboratories, increasing research and development operations also leads to the growing factors for the global specimen validity testing market. These needs the presumptive test as the number of people are misusing the drugs which is continuing to the rise of this market. Presumptive test is the test which is used for the criminal investigation which is not conclusive, but it is used for the screening the presence of a substance in a human body. The partnerships and acquisitions of various main leading manufacturers influence the specimen validity market globally. The government is also taking this market forward by encouraging the research projects and by new prospects.

Technological advancements and increased inclusion of specimen validity testing in the hiring process, schools & universities, and other public places impacted positively on the market. Moreover, the availability of a large number of labs and diagnostic clinics and substitutes of screening tests combined which takes the time to deliver results are the factors which are owing to the growth of the specimen validity testing market. Whereas, the time and cost-intensive process of approval for a rapid test is challenging. In addition, SVT is not considered to be the standard drug testing at workplace and point of care testing. Therefore, it limits the market growth.

The growth of the specimen validity testing market is due to the growth in drug screening market and increase in workplace drug testing. Lack of awareness and emergence of alternative techniques is needed for the growth of the specimen validity testing market. There is a need for the widespread manufacturing of Specimen Validity Testing which includes an increase in the number of foreign travels, cross migrations and other travels all over the world, including a growing population. The restriction to the growth of this market is due to the high costs associated with the operation and maintenance of facilities in the sector. The lack of qualified specialists will lead to the challenge in the growth of market. Excess of unstructured data is expected to slow down the economic growth of the specimen validity testing market.

Many challenges to Specimen Validity Testing Market are brought up by the increasing complexity of interconnecting electronic components, the drop in global commodity prices, and the recent outbreak of COVID-19. The opportunities for the Specimen Validity Testing Market during the forecasted period which are expected to provide are rising demand for networking and storage devices in the data centre, demand for smart healthcare infrastructure, robotics in healthcare applications, and sensor-based devices.
Specimen Validity Testing Market Segment Analysis:
Based on Product & services, The segment reagent, calibrators and controls are expected to grow with the highest market share in terms of revenue in the global market in the year 2022. With increasing use of rapid drug screening test kits globally there rise a demand and purchase in market of reagents and rising in the number of drug screening tests. Due to the repeating purchase of these products, the segment reagent, calibrators and control is growing with the largest market share in year 2022. Reagents are the chemicals which is used in lab for detecting reactions, measuring and for making other substances. Some of the common reagents which are frequently used are Ethylene, Methane, Propane, and Ethane. In order to boost the efficacy of specimen validity testing, there is a rise in research and development activities which has driven demand for the reagents and this leads to the growth of segment.

Based on Type, The specimen validity testing market is segmented into laboratory testing and rapid/POC (Point-of-Care) testing. The segment laboratory testing has largest market share in year 2022. The increased SVT in hospitals and clinics, development in the number of screening labs and rising incidences of drug abuse at workplace and in households leads to the growth of laboratory testing in year 2022. As the laboratory test are cost-saving and provides real-time monitoring, it leads to the routine check-ups and it holds very high state and federal regulatory standards.

Rapid/POC testing segment is also expected to grow with the highest market share in the forecast year. Rapid/POC testing segment have benefits such as instant results, ability to detect multiple drugs at once, and the recurrent & repetitive usage of rapid/POC drug testing products.

Based on End User, The segment workplace is expected to grow at a CAGR of xx% through the forecast period. Due to the increase in preferences for drug screening to take care of employees at the workplace ensuring that they are not on certain medications such as painkillers, OTC medicines and other illicit drugs which affects the work rate and production. Illicit drug is the key factor for the growth of global specimen validity testing market. Drug screening centres and law enforcement agencies adopted specimen validity testing rapidly to make sure the consumption of the illicit drug is prohibited. This is undertaken for eliminating drug abuse and for rehabilitation treatments.


Specimen Validity Testing Market Regional Insights:
The North America region is expected to witness significant growth at a CAGR of xx% through the forecast period. Due to the increased consumption of drugs and other illegal substances at school, colleges and workplace leads to the growth of global specimen validity testing market in North America during the forecast period. The rise in abnormal behaviour, deaths due to overdose, and depression among the young population cause a consumption of alcohol which is common in North America countries such as Russia, Canada and Mexico. This all leads to the contribution of the development of the SVT market. With the USA’s which is contributing most, the presence of key market players, labs, testing kits, technological advancement, and new screening methods impacted positively on the market's growth.

Asia-Pacific is considered to be the second largest growing market share with xx % in the year 2022. Due to rising government expenditure, robust economic growth, increased construction, and incidences of methamphetamine and ketamine leads to the growth of global specimen validity testing market. Over time countries such as India, Sri Lanka, Pakistan, China, and others have noted a rise in the incidence of drug abuse at the workplace and households which prompted authorities to adopt screening tests. Due to high income and urbanization, India reached 6.5 billion alcohol consumption people. The market grows due to the rising number of drug screening labs and elevated government expenditure in Research & Development for the healthcare system.

Addition to this, increased awareness and developed healthcare system in the Middle East & Africa, and South America with the shift of key market players and rise in screening test at workplace in the region are some of the factors leading towards the market growth of the region.

The objective of the report is to present a comprehensive analysis of the Global Specimen Validity Testing Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.

PORTER, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The reports also help in understanding the Global Specimen Validity Testing Market dynamic, structure by analyzing the market segments and projecting the Global Specimen Validity Testing Market size. Clear representation of competitive analysis of key players by Vehicle type, price, financial position, product portfolio, growth strategies, and regional presence in the Global Specimen Validity Testing Market make the report investor’s guide.
Specimen Validity Testing Market Scope: Inquire before buying



Specimen Validity Testing Market


Report Coverage
Details


Base Year:
2022
Forecast Period:
2023-2029


Historical Data:
2017 to 2022
Market Size in 2022:
US $ 2.88 Bn.


Forecast Period 2023 to 2029 CAGR:
9.69 %
Market Size in 2029:
US $ 5.51 Bn.


 Segments Covered:
by Product & Services
• Product
• Reagent, Calibrators, and Controls
• Assay Kits
• Disposables
• Services


by Type
• Laboratory Testing
• Rapid/POC Testing


by End User
• Workplaces
• Drug Screening Laboratories
• Criminal Agency and Law Enforcement Agencies
• Pain Management Centers
• Drug Rehabilitation Center
• Other End Users



Specimen Validity Testing Market, by Region
• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)
Specimen Validity Testing Market Key Players
• Thermo Fisher Scientific, Inc.
• Sciteck
• American Bio Medica Corporation
• Alere
• Express Diagnostics
• Premier Biotech LabCorp.
• Quest Diagnostics
• ACM Global Laboratories
• Clinical Reference Laboratory (CRL)
• SureHire
• CannAmm.
• Danaher Corporation
• Fast Track Diagnostics
• Genway Biotech, Inc.
• Abbott Diagnostics

Frequently Asked Questions:

1] What segments are covered in the Global Specimen Validity Testing Market report?
Ans. The segments covered in the Global Specimen Validity Testing Market report are based on Type and Application.

2] Which region is expected to hold the highest share in the Global Specimen Validity Testing Market?
Ans. North America region is expected to hold the highest share in the Global Specimen Validity Testing Market.

3] What is the market size of the Global Specimen Validity Testing Market by 2029?
Ans. The market size of the Global Specimen Validity Testing Market by 2029 is expected to reach US$ 5.51 Bn.

4] What is the forecast period for the Global Specimen Validity Testing Market?
Ans. The forecast period for the Global Specimen Validity Testing Market is 2023-2029.

5] What was the market size of the Global Specimen Validity Testing Market in 2022?
Ans. The market size of the Global Specimen Validity Testing
Market in 2022 was valued at US$ 2.88 Bn.